System Alert

HRSA will be sending notifications to recipients delinquent in submitting their Single Audits to the Federal Audit Clearinghouse and additional actions will be applied to their HRSA grant(s) for continued noncompliance

 
System Alert

 

Starting April 26, 2024, an Annual Account Review will be initiated for all users on the anniversary of the organization registration, which must be reviewed by the organization/entity’s ‘Primary Authorizing Official’ or the ‘SAM.gov Point of Contact’. 

 
Skip to Main Content

HRSA Electronic Handbooks

Funding Cycle View

Expand

Sickle Cell Disease Treatment Demonstration Program

  • Program Name:Sickle Cell Treatment Demonstration Program
  • Activity Code:U1E
  • Application Available:2/23/2021
  • Application Deadline:5/3/2021
  • Created By:Beach, Dawn
  • Created On:11/7/2019
  • Last Updated by:Wildberger, William
  • Last Updated On:2/23/2021
  • Estimated Project Start Date:9/1/2021
 
Collapse

 Details of the changes posted in this announcement

Not Available
 
Collapse

 Announcement Information

Announcement Number HRSA-21-032
Announcement Code
CFDA Number 93.365
Provisional No
Activity Code U1E
Competitive Yes
Fiscal Year 2021
 
Collapse

 Purpose

This notice announces the opportunity to apply for funding under the Sickle Cell Disease Treatment Demonstration Program (TDP). The purpose of the TDP is to increase access for individuals with sickle cell disease (SCD) to quality, coordinated, comprehensive care by: 1) increasing the number of clinicians or health professionals knowledgeable about the care of SCD, 2) improving the quality of care provided to individuals with SCD, and 3) improving care coordination with other providers.
 
Collapse

 Application Information

Application Available 02/23/2021
Application Deadline 05/03/2021
Supplemental Application Deadline N/A
Explanation for Deadline N/A
Archive Date 07/02/2021
Letter of Intent Not required
Application Package SF424
Allow Applications to be Reopened in EHBs No
FOA Available Yes
Competitive Application Types Supported New; Continuation & Supplement
Allow Electronic Submission N/A
Page Limit for Application
Attachments 		80
Allow Multiple Applications
from an Organization from Grants.gov 		No
Electronic Submission Instruction Electronic submission is/will be available in Grants.Gov
 
Collapse

 General Information

Projected Award Date N/A
Estimated Project Period N/A
Estimated Project Start Date 09/01/2021
Estimated Project End Date 08/31/2026
Estimated Amount of this Competition $5,000,000.00
Estimated Number of Awards 5
Estimated Average Size of Awards $0.00
Cost Sharing No
Cooperative Agreement Yes
 
Collapse

 Contact Information

Name Alisha S. Keehn, MPA
Email akeehn@hrsa.gov
Phone Number (301) 945-4817
 
Collapse

 Download Information

Expand FOA (Guidance) Attachment (Maximum 1)
Document Name Size Date Attached Description
MCHB HRSA-21-032 (U1E) Sickle Cell Disease Treatment Demonstration Program_ Final.pdf 416 kB 02/23/2021
Expand Application Package (Maximum 1)
No documents attached
Expand User Guide (Maximum 1)
No documents attached


Scroll to top